LAUREN PERSON: Open Payments
NPI 1326527300 · HERNANDO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,577 in 73 payments from 18 companies in 2025. Trend: 2023 $2,939 · 2024 $2,278 · 2025 $1,577
Food & beverage: $1,577
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $359 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $295 |
| Viatris Specialty LLC | 7 | $142 |
| Sumitomo Pharma America, Inc. | 6 | $116 |
| Novo Nordisk Inc | 5 | $90 |
| Lilly USA, LLC | 5 | $86 |
| ABBVIE INC. | 4 | $85 |
| Phathom Pharmaceuticals, Inc. | 1 | $81 |
| Amgen Inc. | 3 | $67 |
| PFIZER INC. | 3 | $55 |
Products named: Kerendia, FARXIGA, YUPELRI, GEMTESA, VOQUEZNA, UBRELVY, AIRSUPRA, Ozempic.
Industry payments across MS — which companies pay providers there.
